Speech Treatment for Parkinson's Disease Using Noise-Augmented Automatic Speech Recognition

This study is looking into whether a special speech treatment can help people with Parkinson's disease speak more clearly and participate more in social activities. The treatment uses a web-based app on your phone where you record sentences. This app gives you feedback, even with background noise, to help improve your speech. You would either start this treatment right away or at a later time. We're looking for people aged 50-80 with a Parkinson's diagnosis, stable medication, and mild to moderate speech difficulties (dysarthria). The main goal is to see if this treatment improves how well others understand your speech.

Study design
This interventional study plans to enroll 42 participants. It compares an immediate treatment group with a deferred treatment group.
What's involved
You would have 2-4 initial in-person speech assessments. Then, you would engage in speech treatment sessions at home using your phone and computer four days a week for four weeks.
Compensation
Not stated in the trial record.
Follow-up
Your intelligibility will be measured at 3 years, and the study involves a 6-month follow-up assessment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06540989

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Recruiting
EARLY_PHASE1Ages 50–80InterventionalTreatment
Teachers College, Columbia University
~42 participants
Updated 2024-08-15 on ClinicalTrials.gov
What's tested:Immediate treatmentDeferred treatment

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intelligibility
Measured over 3 years
Parkinson Disease

NCT06540989

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Teachers College, Columbia University

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Gemma Moya-Galé, Ph.D. · PRINCIPAL_INVESTIGATOR · Teachers College, Columbia University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants will qualify for the study if:
They are 50-80 years old,
They have a medical diagnosis of PD,
They are within stages I-IV of Hoehn \& Yahr Scale,
Their antiparkinsonian medication schedule is stable,
They present with mild to moderate dysarthria,
They score ≥ 25 in the MMSE,
They score ≤ 24 in the BDI-III.

Exclusion

Participants will be excluded from the study if they:
Present with atypical parkinsonism at the time of screening (or other neurological condition),
Underwent neurosurgery treatment (DBS),
Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
Present with any speech or voice pathology that is unrelated to PD.
  • Intelligibility3 years

    Transcription accuracy (% words correctly understood by listeners)